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Abstract 
Purpose: The aim of this study was to construct a low-cost, anthropomorphic, and 3D-printed pelvis phantom 
and evaluate the feasibility of its use to perform 3D dosimetry with commercially available bead thermoluminescent 
dosimeters (TLDs). 
Material and methods: A novel anthropomorphic female phantom was developed with all relevant pelvic organs 
to position the bead TLDs. Organs were 3D-printed using acrylonitrile butadiene styrene. Phantom components were 
confirmed to have mass density and computed tomography (CT) numbers similar to relevant tissues. To find out clini-
cally required spatial resolution of beads to cause no perturbation effect, TLDs were positioned with 2.5, 5, and 7.5 mm 
spacing on the surface of syringe. After taking a CT scan and creating a 4-field conformal radiotherapy plan, 3 dose 
planes were extracted from the treatment planning system (TPS) at different depths. By using a 2D-gamma analysis, 
the TPS reports were compared with and without the presence of beads. Moreover, the bead TLDs were placed on the 
organs’ surfaces of the pelvis phantom and exposed to high-dose-rate (HDR) 60Co source. TLDs’ readouts were com-
pared with the TPS calculated doses, and dose surface histograms (DSHs) of organs were plotted. 
Results: 3D-printed phantom organs agreed well with body tissues regarding both their design and radiation 
properties. Furthermore, the 2D-gamma analysis on the syringe showed more than 99% points passed 3%- and 3-mm 
criteria at different depths. By calculating the integral dose of DSHs, the percentage differences were –1.5%, 2%, 5%, 
and 10% for uterus, rectum, bladder, and sigmoid, respectively. Also, combined standard uncertainty was estimated 
as 3.5% (k = 1). 
Conclusions: A customized pelvis phantom was successfully built and assessed to confirm properties similar to 
body tissues. Additionally, no significant perturbation effect with different bead resolutions was presented by the ex-
ternal TPS, with 0.1 mm dose grid resolution.   
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Purpose 
Medical phantoms are artificial representations of hu-
man body structures, which are used in training, audit-
ing, and quality assurance in medicine [1,2]. The aim of 
using them in radiotherapy (RT) is to ensure precision 
dose delivery to the patient with geometric accuracy [2]. 
Depending on their application, phantoms are made of 
different compositions and geometries: from simple cyl-
inders of liquid or solid homogenous materials, such 
as slab phantoms, to complicated multi-material proto-
types [3]. The correspondence between dosimetric phan-
toms and tissue behavior is very important in RT, because 
any radiological inconsistency between the phantom and 
patient’s body, may affect the treatment results and even 
lead to poor treatment outcomes [2,4]. Phantoms, which 
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better indicate tissue properties are called anthropomor-
phic phantoms, and their development in different ap-
plications are an ongoing challenge. Anthropomorphic 
phantoms are representative of human body in terms of 
size, shape, and functions; they are built of structures with 
tissue equivalent material, which represent radiological 
properties of internal organs [2]. In past decades, the us-
age of them was prevalent and beneficial for dosimetric 
inter-comparisons as well as verification procedures and 
patient-specific quality control (PSQC) [5,6]. Moreover, 
the utilization of such phantoms in advanced RT (e.g., 
intensity-modulated radiation therapy (IMRT) and volu-
metric modulated arc therapy (VMAT)), due to the lack 
of lateral electron equilibrium and steep dose gradient in 
small fields, is fundamental [7]. In recent years, several 
studies have shown the advantages of 3D-printed phan-
toms for the use in RT and PSQC [8,9,10]. 
The aim of this study was to develop a novel and low-
cost anthropomorphic pelvis phantom with 3D-printed 
organs and to evaluate the feasibility of its usage to per-
form 3D dosimetry in RT. Micro-silica bead thermolumi-
nescent dosimeters (TLDs) are placed on the surface of 
internal organs and inside the body cavity for 3D dose 
mapping measurements. Although, there are some com-
mercially available or home-made gynecologic (GYN) 
phantoms [11,12,13,14], there is no affordable dosimetric 
GYN phantom, with tissue equivalent composition and 
removable organs, especially for brachytherapy (BT). 
Furthermore, almost all of the existing phantoms, such as 
Rando phantoms, are used to only determine point doses 
in organs or to perform 2D dosimetry. 3D dosimetry, with 
the required positioning accuracy is still not possible. In 
this work, a female pelvis phantom was produced, with 
a simple method using available tissue equivalent materi-
als to obtain 3D dose distribution. 
Material and methods 
Micro-silica bead thermoluminescent dosimeters 
and reading system 
A batch of 500 micro-silica beads (TrueInvivo Ltd., 
UK), 1.5 ±0.1 mm in diameter, 1.0 ±0.1 mm in thickness, 
and 3.7 ±0.1 mg in weight, with material composition (by 
weight), including C – 8.93%, O – 42.18%, Na – 10.55%, 
Al – 1.3%, Si – 33.62%, K – 1.09%, Ca – 1.92%, and Fe – 
0.37%, was employed for this study. These dosimeters 
were selected for the dosimetry because of several of 
characteristics, such as small size, with a chemically in-
ert nature, inexpensive, easy to use and reusable, with 
a fading rate of 10% at 30 days after irradiation and high 
thermoluminescence (TL) light transparency, high sensi-
tivity, and a large dynamic dose range that remains linear 
(R2 ≥ 0.999) from 1 cGy to 25 Gy [15,16,17,18]. 
A Toledo 654 TLD reader (D.A. Pitman Instruments 
Ltd., UK) was employed to readout the bead TLDs manu-
ally at the University of Surrey. In order to obtain the op-
timum full glow-curve by using the present system, the 
readout cycle was initiated, when the planchet reached 
a temperature of 160°C, followed by heating to a maxi-
mum of 350°C at a ramp rate of 20°C/s. 
The individual calibration factors of silica beads were 
determined with a 6 MV photon beam (TPR20/10 = 0.662), 
using a Varian Clinac® 2100C linear accelerator (Varian® 
Medical Systems, Palo Alto, CA, USA) [16]. 
This relative coefficient accounts for the variation of 
individual detector sensitivities in the same TLD batch 
with respect to the physical properties, such as mass and 
dopant concentration, and is defined by the following 
equation: 
              ‹TLR›ECCj = 
______              
 
TLRj,
where ECCj is the ECC of individual bead dosime-
ter j, TLRj is the TL response of dosimeter j, and ‹TLR› 
is the mean TLR of irradiated dosimeters in the same ir-
radiation field. 
This factor is energy-independent in the selected 
range [18] and therefore, the bead TLDs were calibrated 
with a 6 MV photon beam. The final reading of the silica 
beads were obtained by multiplying the raw output val-
ues of TLDs by their individual calibration coefficient. 
Beam perturbation effect 
According to Jafari et al. [18], the effective atomic 
number of silica bead TLDs is equal to 10.6, which is close 
to the effective atomic number of bone (Zeff = 12.31) [19]. 
To estimate the beam perturbation effect of bead TLDs 
and to find the best clinically relevant spatial resolution 
(SR), which was required to arrange the beads on the 
phantom organs’ surfaces, an experiment was performed 
and the effect of the presence of silica beads on beam at-
tenuation was evaluated. The spatial resolution of silica 
beads refers to the separation of them to each other. 
A 5-cc syringe was chosen, and some holes were 
made across its whole surface. The holes had 2.5 mm cen-
ter point spacing (Figure 1A). The reason for selecting the 
syringe was because its material is suitable to observe the 
silica beads individually on computed tomography (CT) 
images. The silica beads were placed on the surface of 
the syringe, with three different spacing: 2.5 mm (high), 
5 mm (medium), and 7.5 mm (low) resolution. The sy-
ringe was positioned on two legs in a reproducible posi-
tion in a water tank (Figure 1B). 
The water tank was filled with water and positioned 
in the RT simulator CT scanner (Figure 1C), and a heli-
cal scan of 2 mm slice thickness was taken. Also, one se-
ries of images was obtained of the syringe without the 
beads. DICOM images were imported into the Pinnacle 
planning system (version 16.02.60004, Philips Health-
care, Andover, USA). From the treatment planning sys-
tem (TPS), 3 dose planes (in 2D format) were extracted at 
different depths, in the middle (source to plane distance 
(SPD) = 99 cm), bottom (SPD = 100 cm), and 2 cm below 
(SPD = 102 cm) the syringe for each TLD’s arrangement. 
By using a 2D-gamma analysis, the TPS reports with and 
without beads were compared. 
Similarly, some artificial “organs”, including rectum, 
bladder, and uterus were contoured on the images ob-
tained with different beads resolution and without them; 
rectum was represented by the syringe, the rectal wall 
by the layer of silica beads over the syringe, the bladder, 
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uterus (clinical target volume – CTV), and uterus +5 mm 
margin (planning target volume – PTV). A 4-field (box) 
conformal treatment plan was performed, with a dose of 
45 Gy/20 fr. The treatment plan was the same for differ-
ent silica bead SR. 
Phantom design criteria 
Dosimetric phantoms in radiotherapy have some 
common requirements, such as suitability in terms of 
transport, radiological tissue equivalence, considering 
physical and electron densities, anatomical accuracy in 
terms of organs’ geometry, and positioning. In addition, 
the other key criteria that are addressed by the current 
phantom included light weight and portability, manu-
facturing from non-toxic and non-degradable materials, 
visually distinguishable organs for the TPS, volume de-
lineation and dose calculation, ability to accommodate 
a large number of silica beads (about 920 silica beads) on 
the organs’ surfaces, reproducible rapid assembly and 
disassembly, and finally, budget and timeline constraints 
satisfaction. 
Phantom features 
The presented anthropomorphic phantom has been 
developed for experimental studies of cervix and uterus 
treatments, and corresponds to a female pelvis of aver-
age body size. It consists of a pelvic skeleton with inter-
skeleton cartilages, uterus, bladder, rectum, and sigmoid. 
For BT usage, a tandem-ring applicator is located in place 
and for external RT, it is removed. The anthropomorphic 
shape of organs represents a realistic clinical situation 
that is important during patient’s simulation. All com-
ponents of the phantom are metal-free to ensure CT and 
magnetic resonance imaging (MRI) compatibility. 
The phantom construction procedure consisted of: 
1. Water tank and base plate preparation, 2. The pelvic 
bone preparation, and 3. Internal organs preparation. The 
following paragraphs describe in detail the phantom con-
struction process. 
Water tank and base plate preparation 
For placing the phantom in the water, a water tank 
with dimensions of 45, 33, and 24 cm3 (length, width, and 
height, respectively) was made. The water tank dimen-
sions were sufficiently large to provide clinically relevant 
scatter conditions. 
Also, a rectangular base plate with dimension of 
29.5, 19.5, and 18 cm3 (length, width, and height, respec-
tively) was made of Perspex material and nylon screws 
(RS Components, UK) to permanently hold the bones in 
the supine lithotomy position. The other organs and the 
A B
C
Fig. 1. A) Syringe with a 2.5 mm spacing arrangement of 
silica bead TLDs, B) The syringe located on the two legs 
into the water tank, C) The positioning of the water tank 
for CT scanning 
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tandem-ring applicator were attached to the bones and 
the base plate, so that they can be placed and removed 
frequently in a reproducible manner. 
The pelvic bone preparation 
A TecTake human skeleton anatomical model life size 
181 cm plus poster plus bonnet was purchased from the 
TecTake prototyping company (UK). The pelvic bones, 
L4, L5 vertebral bodies with their cartilages and femoral 
heads were separated from the other parts of the skeleton 
in the mechanical workshop of the University of Surrey. 
After disassembling every part of the pelvic bone, a lay-
er of ModRac plaster of Paris bandage roll with 2-3 mm 
thickness was adhered to them and then covered with 
a layer of plaster of Paris powder with approximately 
1 mm thickness to make cortical bone equivalent mate-
rial. Then, the bones were painted with oil-based gloss 
paint to waterproof the bones. Eventually, they were re-
assembled to the right shape of the pelvis again. 
3D-printed internal organ construction and printing 
procedure 
Since the direct use of patient scan was so compli-
cated for the practicality of in vivo dosimetry, we need-
ed slightly simplified version of organs to create holes 
on their surface for place and wrap the threaded beads 
over them. Therefore, the internal organ shapes (bladder, 
rectum, sigmoid, and uterus) were initially made with 
a kind of modelling clay by using female pelvic anatomi-
cal references. 
In the external radiotherapy energy range, Compton 
interactions play a key role in photon attenuation, and de-
pendent on the atomic number and the electron density 
of the attenuator, the initial hypothesis was because of the 
similarity of effective atomic number of modelling clay 
(Zeff = 7.6) [20] and water (Zeff = 7.4), this material is suit-
able for dosimetric purposes in therapeutic photon ener-
gies (we wanted to construct a low-cost phantom and use 
it both in external RT and brachytherapy). However, the 
CT images revealed that the CT number of the polymer 
clays was similar to the bone, which means that it affected 
the photon attenuation coefficients, leading to dose calcu-
lation errors in megavoltage energies. Hence, we changed 
our methods and the CT images of the patient were used 
to produce 3D-printed organs. Furthermore, we used the 
initial organs (built with clay) for fixing into the phantom, 
which was really important. Finally, they were replaced 
with the 3D-printed organs for the real measurement. 
In the following, axial CT images of an anonymous 
40-year-old female patient (supine position) were ob-
tained as per normal departmental protocols, using 
a RT simulator CT scanner (Toshiba Asteion, 4-slice CT 
scanner). The internal organs, including uterus, blad-
der, rectum, and sigmoid were delineated by an expert 
medical physicist using Pinnacle TPS. The uterus was an 
oval shape, with an approximate size of 6, 4, and 10 cm3 
(length, width, and height, respectively), the bladder was 
a conical shape, with an approximate size of 10, 6, and 
5 cm3 (length, width, and height, respectively), and rec-
tum and sigmoid were bent cylindrical shapes with ap-
proximate sizes of 2 cm and 14 cm (diameter and length, 
respectively). The DICOM images with delineated struc-
tures were transferred into 3D slicer v.4.1 [21,22]. Within 
this software, the segmentation editor was used to select 
individual organs and produce 3D mesh objects, which 
were exported to stereolithography (STL) files. The STL 
files were then processed in Autodesk® Fusion 360™ 
vs. 2.0 (2018, Autodesk, San Rafael, CA, USA), that were 
used as a reference to construct native solid bodies in the 
software. Holes of 2.5 mm depth and 2.2 mm in diameter 
for the positioning of the silica beads were created on the 
body’s surface. The holes had 5 mm center point spacing 
and followed the contours of the model, and slots were 
created between holes for the thread connecting them 
to lie. The organ models (Figure 2A) including the holes 
were then exported to STL for 3D printing. The printing 
parameters are summarized in Table 1. 
In this study, ABS filaments were used to print the 
organs due to its density (1.05 g/cm3) and other proper-
ties’ similarity to water [23,24]. A fused deposition mod-
elling (FDM) 3D printer (CubePro, 3D Systems Inc., USA) 
was chosen to print the models due to its ability to print 
ABS layer-by-layer to create a 3D object. The printer has 
a heated bed and enclosure, which aids in ABS printing. 
Phantom assembly, irradiation plan,  
and evaluation methods 
After assembling the phantom (Figure 2B) and placing 
it into the water tank, a helical CT scan was taken (Toshi-
ba Asteion 4-slice CT scanner, tube voltage 120 kVp; tube 
current 100 mA; 512, 512 pixels; 1 mm slice interval and 
thickness; Figure 2C). The images were imported into 
the Pinnacle TPS. To evaluate the feasibility of using the 
3D-printed phantom for dosimetry, the phantom proper-
ties were compared with solid water. The mass density 
and CT numbers of organs were sampled, using the re-
gion-of-interest software tool within the planning system 
and compared with Pinnacle’s lookup table. 
Then, silica beads were threaded and placed on the 
organs’ surface in a square grid with 1 cm resolution, 
and a helical CT scan was taken from the phantom. The 
bead TLDs were exposed to the CT scan, as it was not 
possible to assemble them again after the CT scan. To ad-
dress the issue of beads undergoing CT scan before BT ir-
radiation in the anthropomorphic phantom, 30 beads (in 
3 groups of 10 beads) were placed near each organ in the 
water tank. After performing the scan, these beads were 
removed and processed separately. The obtained doses 
were subsequently deducted from the doses measured in 
beads from the delivered BT plan. 
The images were imported into the Sagiplan® TPS 
(Eckert & Ziegler GmbH, Germany) and a treatment plan 
was created to deliver 7 Gy prescribed to ICRU38 defined 
A-points in the above-mentioned phantom (Figure 3). 162, 
150, 94, and 52 silica beads were located on the uterus, 
bladder, rectum, and sigmoid, respectively. The phantom 
with bead TLDs was irradiated with a HDR 60Co source 
(Eckert & Ziegler GmbH, Germany) according to the 
planned dose distribution (Figure 2D). Due to the rapid 
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dose fall-off around BT sources, the beads were irradiated 
with different doses. According to the time, this represents 
a variation in dose rates. Additionally, in a publication by 
Jafari et al. it was shown that the response of beads is in-
dependent of the incident dose-rate [17]. The bead TLDs 
readout and the predicted dose extraction of correspond-
ing points from TPS were performed. Finally, the percent-
age difference of mean doses and dose surface histograms 
(DSHs) of the measured doses were compared against the 
TPS calculated doses for the uterus as CTV, and for the 
bladder, rectum, and sigmoid as organs at risk (OARs). 
The uncertainty budget of silica bead TLDs measure-
ments at this phase, included 2.7% for determination of the 
element correction coefficients (ECCs) for each bead TLD, 
0.1% for dose response linearity of silica bead TLD [15], 
2.0% for TLD reading process [16], 0.5% for bead calibra-
tion [16], and 1% for energy dependency of silica beads 
[25], which leads to 3.5% (k = 1) of combined standard un-
certainty. 
Results 
Evaluating photon beam perturbation 
Comparing organs doses according to DVHs 
After calculating the dose distribution with the box 
3D conformal plan, the dose volume histograms (DVHs) 




Fig. 2. A) 3D model view of the organs, B) 3D-printed organs with placement of thermoluminescent dosimeters (TLDs) at their 
surface, C) The anthropomorphic pelvis phantom in the water tank on the CT coach, D) The phantom in the water tank con-
nected to high-dose-rate (HDR) unit
Table 1. 3D-printing parameters to construct the 
pelvis phantom organs 
Setting Value 
Bed temperature 40°C 
Extruder temperature 160°C 
Layer height 0.2 mm 
First layer height 0.2 mm 
Vertical shells N/A 
Horizontal shells N/A 
Speed of print movement (perimeter) 80.0 mm/s 
Speed of print movement (external perimeter) 50% 
Speed of print movement (infill) 80% 
First layer print movement speed 80.0 mm/s 
Fill density 90% 
Fill pattern Solid 
Fill angle 0 
Nozzle diameter 0.40 mm 
Filament diameter 1.5 mm 
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centage differences of the delivered dose to organs with 
the presence of silica beads (with different resolutions) 
and without beads were obtained (Tables 2 and 3). Ac-
cording to these numbers, there was no significant dif-
ference between the absorbed doses of organs with silica 
beads in various SR. 
Gamma evaluation method 
Low et al. [26] defined the gamma index (γ) to com-
pare the distributions of calculated and measured doses. 
In this part of the project, γ index evaluation was used to 
find out whether the silica beads have any effect on radia-
tion transmission and radiation field perturbation. Veri-
Soft software (v.7.1, PTW, Germany) was used to com-
Fig. 3. High-dose-rate (HDR) plan on the CT image of the phantom (coronal and axial view); each thermoluminescent dosimeter 
(TLD) is clearly visible 
Table 2. Result of the organs’ dose obtained at different silica bead resolution on the syringe according to 
DVH (the doses are in cGy)  
Organs (mean dose) No bead Hresa (2.5 mm) Mresb (5 mm) Lresc (7.5 mm) 
Rectum 3449.59 3445.89 3448.44 3449.36 
Rectal wall 3639.23 3634.43 3638.47 3638.79 
Bladder 3578.50 3576.96 3578.53 3578.50 
CTV 4522.45 4519.65 4522.21 4522.44 
PTV 4491.17 4488.50 4490.79 4491.14 
ahigh resolution, bmedium resolution, clow resolution
Table 3. Result of percentage dose differences of 
the organs at different silica bead resolution on 







Rectum 0.11 0.03 0.00 
Rectal wall 0.13 0.02 0.01 
Bladder 0.04 0.00 0.00 
CTV 0.06 0.01 0.00 
PTV 0.06 0.01 0.00 
ahigh resolution, bmedium resolution, clow resolution 
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pare the dose of the plane with no beads as a reference, 
and the planes including beads with different SR at dif-
ferent distances from the source (different SPD). Tables 4 
and 5 present the results of these comparisons. 
According to these tables, the 2D-γ analysis on the sy-
ringe showed more than 99% points passed 3% and 3 mm 
(also 2% and 2 mm) criteria at all SPDs, which means that 
external treatment planning with 0.1 mm dose grid reso-
lution did not present any significant perturbation effects 
due to the presence of bead TLDs with different SR.
 
Evaluation and measurement on the phantom 
Physical evaluation 
We found that the 3D-printed internal organ materi-
als have an average physical density ρ, electron density 
(relative to water), and CT numbers of 0.95 ±0.01 g/cm3, 
0.97 ±0.01, and 959 ±5, respectively (solid water: CT num-
ber = 1012, 0.944 < ρ < 1.044 g/cm3), based on a Pinnacle’s 
lookup table. 
Dosimetric evaluation 
Figure 4 shows the DSHs of measured doses with 
TLDs in comparison with those of the TPS calculation. By 
calculating the integral dose for the organs, the percent-
age differences were found to be –1.5%, 2%, 5%, and 10% 
for uterus, rectum, bladder, and sigmoid, respectively. 
Also, the results showed that the mean absolute dose dif-
ference of TLD measurements compared to the TPS cal-
culations were –4.5 ±19.5 cGy, 4.8 ±9.5 cGy, 4.3 ±8.7  cGy, 
and 2.9 ±5.1 cGy (1 SD) in the uterus, rectum, bladder, and 
sigmoid, respectively, which were –1.4 ±6.1%, 2.1 ±4.1%, 
5.2 ±10.6%, and 10.9 ±18.7% (1 SD) of the TPS mean doses 
(negative sign indicates larger measured dose). The mean 
doses of TLD reading were higher than those calculated 
by the TPS in the uterus. Although the percentage differ-
ences were higher for the beads located on the bladder 
and sigmoid, this occurred for regions with mean dos-
es < 1 Gy (at distances approximately 10 cm and more 
from the source), which is not important in real BT clini-
cal situation. Finding high variation in percentage dose 
differences was due to the steep dose fall-off, which oc-
curs in BT radiation fields. In this study, this was more 
evident in a low-dose region, since a small difference in 
absolute dose led to a high percentage of difference. 
On the other hand, these high differences may arise 
from the energy dependency of bead TLDs’ response to 
low energy photons. According to Jafari et al. [18], the 
greater energy dependency of bead TLDs in a lower en-
ergy range (< 100 keV) can be explained by the non-soft 
tissue equivalence (silicon-based) of beads, as the pho-
toelectric process is the dominant interaction in this re-
gion. Therefore, the attenuation coefficient of bead TLDs 
and their energy response at far distances from the BT 
source may need more investigation using Monte Carlo 
simulation. 
Timeline and costs 
The timeline and cost of the organs are shown in Ta-
ble 6. The cost for the human body skeleton was 100 GBP, 
the water tank and base plate came to 105 GBP, and 
60 GBP for the ABS cartridge. Therefore, the total price 
Table 4. Result of the comparing planes with 
and without beads at different source to plane 
distance (SPDs) and different bead resolutions 






SPD = 102 cm
High resolution (2.5 mm) 0.071 0.246 
Medium resolution (5.0 mm) 0.008 0.026 
Low resolution (7.5 mm) 0.001 0.004 
SPD = 100 cm 
High resolution (2.5 mm) 0.080 0.299 
Medium resolution (5.0 mm) 0.014 0.053 
Low resolution (7.5 mm) 0.003 0.009 
SPD = 99 cm 
High resolution (2.5 mm) 0.064 0.952 
Medium resolution (5.0 mm) 0.007 0.676 
Low resolution (7.5 mm) 0.003 0.659 
Table 5. Result of the comparing planes with 
and without beads at different source to plane 
distance (SPDs) and different bead resolutions 
on the syringe with Verisoft software (2%, 2 mm 





SPD = 102 cm
High resolution (2.5 mm) 0.107 0.246 
Medium resolution (5.0 mm) 0.011 0.026 
Low resolution (7.5 mm) 0.002 0.004 
SPD = 100 cm 
High resolution (2.5 mm) 0.120 0.299 
Medium resolution (5.0 mm) 0.021 0.053 
Low resolution (7.5 mm) 0.004 0.009 
SPD = 99 cm 
High resolution (2.5 mm) 0.096 0.952 
Medium resolution (5.0 mm) 0.010 0.676 
Low resolution (7.5 mm) 0.004 0.659 
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fill density and infill pattern of materials with different 
3D-printing systems. It appears that depending on the in-
tended application, specific settings should be considered 
to use with any 3D printer and material. Therefore, ABS 
and polylactic acid (PLA) plastics were tested with differ-
ent fill densities. Eventually, it was found that ABS with 
Table 6. Print statistics for each individual internal 
organ in the anthropomorphic pelvis phantom 
Organ Print  
time (h) 
Mass (g) Print cost 
(GBP) 
Bladder 5.56 42.3 40 
Uterus 5.42 85.2 40 
Rectum and sigmoid 7.07 27.1 40 
Total 18.05 154.6 120 
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Fig. 4. Dose surface histograms obtained by thermoluminescent dosimeters (TLDs) readout and point doses calculation of treat-
ment planning system (TPS)
was 385 GBP for materials, which was comparable to oth-
er commercial phantoms. 
The weight of the water tank and base plate with 
bones and organs were approximately 5 kg. The weights 
of them with full water tank were approximately 40 kg. 
Discussion 
In this study, a phantom was needed to place the sil-
ica beads TLDs similar to real organ position, but it was 
found that commercial phantoms were not suitable for 
this purpose; so, it was decided to construct an anthropo-
morphic and low-cost pelvis phantom for the use in 3D 
dosimetry of external RT and BT. 
Phantoms used in radiation dosimetry should be made 
of materials that render the same radiological properties 
as the real organ tissues, especially in terms of the radia-
tion attenuation. Although various 3D-printing materials 
have been studied [2,8,9,13,23,24], there is no agreement 
on printing parameters and settings used, such as the in-
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90% fill density was best suited for mimicking human 
soft tissues by using the CubePro 3D printer. Bladder and 
rectum were 3D printed as hollow objects, with a 90% in-
filled outer boundary (with thickness about 5-6 mm) and 
the uterus was solid. 
The constructed phantom and organs, which are 
shown in Figure 2B, were simple to assemble; organs 
could be repositioned with no discernible displacement. 
The values of CT number and the other parameters of the 
organs indicate agreement between them, with relevant 
tissues within the tolerances. 
In this project, it was necessary to obtain clinically 
relevant SR required for placing the silica beads at the or-
gans’ surface, which does not cause significant perturba-
tion effect. Locating the dosimeter on the path of central 
axis of the radiation field is a popular method for measur-
ing beam perturbation. Until now, the beam perturbation 
effect was measured for different dosimeters specially di-
odes [27,28], which are the commonly used one for in vivo 
dosimetry. Since it was desired to evaluate this effect in 
the presence of a large number of bead TLDs, a special 
test was designed. The bead TLDs were arranged on the 
surface of a syringe with different SR and placed in the 
water tank for CT scanning. As the results showed, de-
spite the beads TLD’s relatively high density and atomic 
number, they minimally perturb the radiation field due 
to their small size, causing no considerable decrease or 
increase in dose. 
Silva et al. in 2015 performed a dosimetric study on an 
anthropomorphic phantom to investigate a bladder dose. 
They exposed radiochromic film (strips with a width of 
1 cm) and optically simulated luminescent dosimeters 
(OSLDs) with a diameter of 5.0 mm and thickness of 
1.0 mm, using a HDR 192Ir source on the surface of two 
3D-printed bladders. The study has shown that approxi-
mately 83% and 66.7% of the doses measured using film 
exhibited discrepancies lower than 10% and 5% with the 
results obtained by TPS. They have estimated the ex-
panded uncertainty of 8.6% in the film calibration proce-
dure. Also, approximately 92% of OSLD results (36 mea-
surement points) illustrated percentage differences lower 
than 10% [13]. In this study, although most of the results 
obtained using films and OSL dosimeters were in agree-
ment with those acquired by the TPS, significant differ-
ences occurred in some points, such as between the film 
and TPS (25.3%) and the film and OSLD (–22.1%) on the 
anterior wall of bladder. 
In another GYN patient in vivo dosimetry performed 
by Sharma et al. [29], OSLDs (nanodots with a disk sen-
sible volume of 5 mm in diameter and 0.2 mm thick) were 
placed on modified rectal retractors and exposed with 
a HDR 192Ir source. They found that the range of differ-
ences between the measured and TPS calculated doses 
(20 points) was –10.1% to 13.7% with Acuros algorithm 
and –14.9% to 11.6% with TG-43 algorithm. 
According to the number of the bead TLDs, which was 
utilized for high resolution surface dosimetry of the pel-
vis organs in the unique constructed phantom, the results 
may not be comparable with the other point dosimeters, 
but they can render a relative viewpoint to the leadership. 
Eventually, summarizing dose distribution through-
out the organ volumes is customarily estimated by using 
DVHs. For hollow organs, like the rectum and bladder, 
the dose received by these organs’ contents is not impor-
tant, therefore some researchers [30,31,32,33] suggested 
working with dose wall histograms (DWHs) and DSHs, 
which are more clinically relevant to evaluate the dose 
distribution created over these organs. In this regard, by 
using a large number of bead TLDs on the organs’ sur-
faces and performing 3D dosimetry, obtaining the DSHs 
of the organs has been achieved. 
Conclusions 
In this study, an anthropomorphic pelvis phantom 
was successfully constructed for performing 3D dosim-
etry using silica bead TLDs. The phantom consists of pel-
vic organs, which are relevant in GYN treatment, and can 
be used for external RT and BT. A 90% ABS infill density 
was found to result in a material suitable for modelling 
soft tissue, with CT scan images showing good contrast 
between anatomical structures. The constraint of the cur-
rent project was handling and reading out a large number 
of silica beads, which were labor-intensive and time-con-
suming procedures. This inhibited performing BT dosim-
etry under different doses and treatment plans, which is 
a limitation of this study. More investigation might be 
helpful to provide better understanding of the behavior 
of the phantom under different clinical conditions. Al-
though the bead TLD responses were assessed already in 
external RT by Jafari et al. [15,16,17,34], it could be better 
to execute an external RT plan on this phantom within the 
presence of the silica beads. 
The results of the current project demonstrate that 
the developed phantom and also commercially available 
silica bead TLDs are suitable for dosimetric studies of 
GYN treatments. Also, for the first time, plotting DSHs 
using the measurements of a large number of dosimeters 
is possible. 
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